Cohort study on immune checkpoint inhibitor-associated acute kidney injury: Incidence, risk factors, and management strategies.

Autor: Panich, Jennifer, Irwin, Craig, Bissonette, Adam, Elkhidir, Sabri, Lodhi, Fahad, Folz, Connie, Lee, Joshua, Pulipati, Soumya, Fatima, Zebi, Gopinath, Prathima, Blonsky, Rebecca, Abboud Leon, Chady, Kattamanchi, Siddhartha

Publikováno v: Journal of Oncology Pharmacy Practice; Mar2024, Vol. 30 Issue 2, p286-294, 9p

sj-docx-1-opp-10.1177_10781552231171078 - Supplemental material for Cohort study on immune checkpoint inhibitor-associated acute kidney injury: Incidence, risk factors, and management strategies

Autor: Panich, Jennifer, Irwin, Craig, Bissonette, Adam, Elkhidir, Sabri, Lodhi, Fahad, Folz, Connie, Lee, Joshua, Pulipati, Soumya, Fatima, Zebi, Gopinath, Prathima, Blonsky, Rebecca, Abboud Leon, Chady, Kattamanchi, Siddhartha

Supplemental material, sj-docx-1-opp-10.1177_10781552231171078 for Cohort study on immune checkpoint inhibitor-associated acute kidney injury: Incidence, risk factors, and management strategies by Jennifer Panich, Craig Irwin, Adam Bissonette, Sabri

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::798c7da67b53dea830f6473cd96a1464

Updates in Treatment of HER2-positive Metastatic Breast Cancer.

Autor: Avelino ARM; Division of Hematology-Oncology, University of Massachusetts Chan Medical School - Baystate, Springfield, MA, USA., Pulipati S; Division of Hematology-Oncology, University of Massachusetts Chan Medical School - Baystate, Springfield, MA, USA., Jamouss K; Department of Internal Medicine, University of Massachusetts Chan Medical School - Baystate, Springfield, MA, USA., Bhardwaj PV; Division of Hematology-Oncology, University of Massachusetts Chan Medical School - Baystate, Springfield, MA, USA. Prarthna.bhardwaj@baystatehealth.org.

Publikováno v: Current treatment options in oncology [Curr Treat Options Oncol] 2024 Nov 09. Date of Electronic Publication: 2024 Nov 09.